Indicated for: hyperparathyroidism
Route of administration: oral
Substance: paricalcitol (vitamin D / vitamin D analogue)
ATC: H05BX02 (Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents)
Paricalcitol is a vitamin D analog used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. It helps regulate calcium and phosphorus levels in the body, reducing excessive secretion of parathyroid hormone (PTH).
The medication is administered intravenously or orally, as directed by your doctor. It is important to monitor calcium, phosphorus, and PTH levels during treatment to prevent complications.
Side effects may include nausea, itching, hypercalcemia, or, in rare cases, severe allergic reactions.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as bone or kidney diseases, to ensure the safe use of paricalcitol.